NRG1 as a Therapeutic Target

Dec 28, 2021
Episode
91
Share

Dr. Jacques Cadranel, Head of Department Pulmonology and Thoracic Oncology, Assistance Publique Hôpitaux de Paris and Sorbonne University and Dr. Janessa Laskin, Medical Oncologist at the Vancouver Cancer Centre in British Columbia, Canada join Lung Cancer Considered Host Dr. Narjust Duma to discuss current and promising breakthrough therapies in lung cancer.

Guest
Narjust Florez
Narjust Florez

MD

Associate Director of the Cancer Care Equity Program and Assistant Professor of Medicine
Dana-Farber Cancer Institute
Harvard Medical School
Man standing in front of book shelves he is wearing a white coat
Jacques Cadranel

MD

Head of Department Pulmonology and Thoracic Oncology
Assistance Publique Hôpitaux de Paris and Sorbonne University
Woman smiling she is wearing scrubs and a stethoscope. She appears friendly
Janessa Laskin

MD

Medical Oncologist
Vancouver Cancer Centre in British Columbia

Other Podcast